Karen Klahr Miller, MD

Quick facts

Phase 3 pipeline

• Romosozumab Prefilled Syringe · Bone disorders
  Romosozumab Prefilled Syringe is a monoclonal antibody that targets sclerostin to increase bone formation and decrease bone resorption.

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• Karen Klahr Miller, MD portfolio CI brief
• Karen Klahr Miller, MD pipeline updates RSS